Shanghai HeartCare Medical Technology Corp Ltd
HKEX:6609
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Shanghai HeartCare Medical Technology Corp Ltd
Selling, General & Administrative
Shanghai HeartCare Medical Technology Corp Ltd
Selling, General & Administrative Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Shanghai HeartCare Medical Technology Corp Ltd
HKEX:6609
|
Selling, General & Administrative
-¥187.1m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
A
|
APT Medical Inc
SSE:688617
|
Selling, General & Administrative
-¥582.8m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Selling, General & Administrative
-¥2.3B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-18%
|
|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Selling, General & Administrative
-¥6.6B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
|
Andon Health Co Ltd
SZSE:002432
|
Selling, General & Administrative
-¥931.1m
|
CAGR 3-Years
16%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-16%
|
|
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Selling, General & Administrative
-¥2.5B
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
Shanghai HeartCare Medical Technology Corp Ltd
Glance View
Shanghai Heartcare Medical Technology Corp. Ltd. engages in the research, development, manufacture, and sale of neuro-interventional medical devices. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2021-08-20. The firm's product portfolio includes both neuro-interventional and cardiac medical devices, and its main products are CaptorTM thrombectomy device (Captor) and left atrial appendage occluder. The firm's product portfolio extends from the treatment and prevention of ischemic stroke, including acute ischemic stroke and intracranial stenosis to the treatment of hemorrhagic stroke. The firm's other products include the balloon guiding catheter, the ExtraFlex distal access catheter and SupSelek microcatheter. The firm distributes its products within the domestic market.
See Also
What is Shanghai HeartCare Medical Technology Corp Ltd's Selling, General & Administrative?
Selling, General & Administrative
-187.1m
CNY
Based on the financial report for Dec 31, 2025, Shanghai HeartCare Medical Technology Corp Ltd's Selling, General & Administrative amounts to -187.1m CNY.
What is Shanghai HeartCare Medical Technology Corp Ltd's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
-4%
Over the last year, the Selling, General & Administrative growth was -27%. The average annual Selling, General & Administrative growth rates for Shanghai HeartCare Medical Technology Corp Ltd have been -4% over the past three years , -4% over the past five years .
